Embla Medical hf
Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics and Neuro Orthotics, Bracing and Supports, and Patient Care. The Prosthetics and Neuro Orthotics segment offers mechanical products, such as lower and upper limb loss or difference; and … Read more
Market Cap & Net Worth: Embla Medical hf (EMBLA)
Embla Medical hf (CO:EMBLA) has a market capitalization of $1.62 Billion (Dkr11.80 Billion) as of March 18, 2026. Listed on the CO stock exchange, this Denmark-based company holds position #9300 globally and #17 in its home market, demonstrating a -6.76% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Embla Medical hf's stock price Dkr27.60 by its total outstanding shares 427545638 (427.55 Million).
Embla Medical hf Market Cap History: 2015 to 2026
Embla Medical hf's market capitalization history from 2015 to 2026. Data shows growth from $1.36 Billion to $1.62 Billion (2.16% CAGR).
Embla Medical hf Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Embla Medical hf's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.98x
Embla Medical hf's market cap is 1.98 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
22.12x
Embla Medical hf's market cap is 22.12 times its annual earnings
1.97x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $2.85 Billion | $629.50 Million | $6.21 Million | 4.53x | 458.80x |
| 2021 | $2.49 Billion | $718.67 Million | $63.99 Million | 3.46x | 38.90x |
| 2022 | $1.97 Billion | $718.65 Million | $42.51 Million | 2.75x | 46.44x |
| 2023 | $1.62 Billion | $799.07 Million | $58.39 Million | 2.02x | 27.66x |
| 2024 | $2.09 Billion | $854.89 Million | $68.28 Million | 2.45x | 30.68x |
| 2025 | $1.91 Billion | $963.59 Million | $86.47 Million | 1.98x | 22.12x |
Competitor Companies of EMBLA by Market Capitalization
Companies near Embla Medical hf in the global market cap rankings as of March 18, 2026.
Key companies related to Embla Medical hf by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #79 globally with a market cap of $190.05 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #153 globally with a market cap of $121.18 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #169 globally with a market cap of $112.92 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #191 globally with a market cap of $103.18 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #79 | Abbott Laboratories | NYSE:ABT | $190.05 Billion | $109.95 |
| #153 | Stryker Corporation | NYSE:SYK | $121.18 Billion | $349.56 |
| #169 | Medtronic PLC | NYSE:MDT | $112.92 Billion | $88.24 |
| #191 | Boston Scientific Corp | NYSE:BSX | $103.18 Billion | $69.79 |
Embla Medical hf Historical Marketcap From 2015 to 2026
Between 2015 and today, Embla Medical hf's market cap moved from $1.36 Billion to $ 1.62 Billion, with a yearly change of 2.16%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Dkr1.62 Billion | -15.08% |
| 2025 | Dkr1.91 Billion | -8.71% |
| 2024 | Dkr2.09 Billion | +29.69% |
| 2023 | Dkr1.62 Billion | -18.18% |
| 2022 | Dkr1.97 Billion | -20.69% |
| 2021 | Dkr2.49 Billion | -12.69% |
| 2020 | Dkr2.85 Billion | -6.97% |
| 2019 | Dkr3.06 Billion | +68.90% |
| 2018 | Dkr1.81 Billion | +17.42% |
| 2017 | Dkr1.55 Billion | +6.28% |
| 2016 | Dkr1.45 Billion | +6.65% |
| 2015 | Dkr1.36 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Embla Medical hf was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.62 Billion USD |
| MoneyControl | $1.62 Billion USD |
| MarketWatch | $1.62 Billion USD |
| marketcap.company | $1.62 Billion USD |
| Reuters | $1.62 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.